Precise targeting of genomic cuts has been possible for some time, but more expensive:
https://en.wikipedia.org/wiki/Zinc_finger_nuclease
https://en.wikipedia.org/wiki/Transcription_activator-like_e...
https://en.wikipedia.org/wiki/Zinc_finger_nuclease
https://en.wikipedia.org/wiki/Transcription_activator-like_e...
As for updating "live" code...that's a flawed, but not completely wrong analogy. Other techniques do rely on modifying the genome before "production", and in that sense CRISPR does enable us to edit DNA in cases that would have been impractical before, but it still basically requires performing the modification on each cell individually -- so there are still practical limits on deploying the technique.